Skip to main content
Category

News Archive

NewImage

The Center for Innovative Technology Announces Bob Stolle as Chief Executive Officer and President

By News Archive

NewImage

Richmond, VA, Sept. 11, 2020 (GLOBE NEWSWIRE) — The Center for Innovative Technology (CIT) Board of Directors today announced Bob Stolle as the organization’s Chief Executive Officer and President of CIT. Stolle previously served as CIT’s Senior Vice President of Policy and Regional Initiatives as well as the head of CIT’s Entrepreneurial Ecosystems Division.

“Virginia’s entrepreneurship community has grown tremendously during Ed Albrigo’s tenure at CIT, and we are grateful for his dedicated service to our Commonwealth,” said Governor Ralph Northam. “I am pleased to welcome Bob Stolle to lead the agency and its efforts to advance our innovation economy.”

Image: The Center for Innovative Technology Announces Bob Stolle as Chief Executive Officer and President – https://www.globenewswire.com

Read More
Governor Hogan Announces Acquisition of 250 000 Rapid Antigen Tests from Becton Dickinson thebaynet com TheBayNet com Articles

Governor Hogan Announces Acquisition of 250,000 Rapid Antigen Tests from Becton Dickinson | thebaynet.com | TheBayNet.com | Articles

By News Archive

Governor Hogan Announces Acquisition of 250 000 Rapid Antigen Tests from Becton Dickinson thebaynet com TheBayNet com Articles

ANNAPOLIS, Md. – Governor Larry Hogan today announced the acquisition of 250,000 rapid point-of-care antigen tests, which will be deployed to nursing homes, assisted-living facilities, and correctional and juvenile detention centers across the state. The purchase makes Maryland, the founding member of the bipartisan interstate testing compact with the Rockefeller Foundation, the first state in the compact to move forward with an order for rapid antigen tests.

Image: https://www.thebaynet.com

Read More
Immunomic Therapeutics Inc Expands into South Korea Immunomic Therapeutics

Immunomic Therapeutics Inc. Expands into South Korea – Immunomic Therapeutics

By News Archive

Immunomic Therapeutics Inc Expands into South Korea Immunomic Therapeutics

Seoul Office Will Be Opening to Develop Immunomic Therapeutics Investigational Cell Therapy for Brain Cancer

September 10, 2020 08:00 AM Eastern Daylight Time SEOUL–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, originating in the United States recently opened its first office in South Korea. This continues to build on ITI’s overall strategy to be the partner-of-choice for innovative biotechnology companies in emerging centers of excellence worldwide.

 

Read More
Scientist Working in Laboratory Free Stock Photo

Md. Labs Developing Vaccines and Therapeutics, Attracting Federal Dollars – Maryland Matters

By News Archive

Scientist Working in Laboratory Free Stock Photo

A 2016 decision to link the research labs at the University of Maryland College Park with those at the University of Maryland at Baltimore is paying dividends in the competition for federal COVID-19 research dollars, a top education official told a science advisory panel on Wednesday. 

The decision was a spinoff of the University of Maryland Strategic Partnership Act, said Laurie Ellen Locasio, vice president for research at the two institutions. 

 

Read More
NewImage

Top 5 TED Talks on Gene Technology that Every Biotech Leader Must Watch | American Gene Technology

By News Archive

NewImage

TED Talks began in 1984 as a conference originating in Silicon Valley where powerful voices in Technology, Entertainment, and Design came together to spread potent ideas with broad relevance. Today there are thousands of talks of 18 minutes or less, in more than 100 languages, covering topics ranging from science to global issues. Despite this diversity, all TED talks share a devotion to Ideas Worth Spreading.

Image: https://www.americangene.com

Read More
NewImage

NIH continues to boost national COVID-19 testing capacity | National Institutes of Health (NIH)

By News Archive

NewImage

The National Institutes of Health today announced $129.3 million in scale-up and manufacturing support for a new set of COVID-19 testing technologies as part of its Rapid Acceleration of Diagnostics (RADx) initiative. NIH is awarding contracts to nine companies for technologies that include portable point-of-care tests for immediate results and high-throughput laboratories that can return results within 24 hours. These tests add to initial awards made to seven companies on July 31, 2020.

Image: MatMaCorp’s Solas 8 portable detection system for SARS-CoV-2 is designed to improve on-site testing capabilities of CLIA labs in rural communities.MatMaCorp

Read More

California Developer Plans 169,812 Sq. Ft. Lab and Office Building in Port Covington

By News Archive

Alexandria logo

Pasadena, California-based Alexandria Real Estate Equities, Inc. is planning a six-story, 169,812 sq. ft. lab and office building in Port Covington. The project is a collaboration between Alexandria and The Port Covington Development Team.

This building is proposed for lot E8 on the Chapter 1B Master Plan of the Port Covington project. This lot fronts a newly-aligned Cromwell St. and is adjacent to the northeast of the Rye Street Market complex. Rye Street Market is three connected buildings that make up 275,000 sq. ft. with 185,000 sq. ft. of office space, a 13,000 sq. ft. open-air market and food hall, 50,000 sq. ft. of pedestrian-oriented retail, a 12,000 sq. ft. meeting facility, and a 15,000 sq. ft. rooftop event space.

 

Read More
Virginia Tech Research Sees Continued Growth The Roanoke Star News

Virginia Tech Research Sees Continued Growth – The Roanoke Star News

By News Archive

Virginia Tech Research Sees Continued Growth The Roanoke Star News

Virginia Tech’s research expenditures are up, in addition to an increase in sponsored awards by 15 percent, building upon the last fiscal year’s expenditure total of $542 million, despite the impact of COVID-19 felt nationally by higher education institutes, according to preliminary fiscal year end reports.

Image: Researchers Nisha Duggal (left) and James Weger-Lucarelli from the Fralin Life Sciences Institute and Virginia-Maryland College of Veterinary Medicine are establishing a reverse genetics system for SARS-CoV-2 that will serve as the basis for vaccine design. Photo: Ray Meese, Virginia Tech. – https://theroanokestar.com

Read More
In Conversation with Troy LeMaile Stovall TEDCO s New CEO and Executive Director BioBuzz

In Conversation with Troy LeMaile-Stovall, TEDCO’s New CEO and Executive Director · BioBuzz

By News Archive

In Conversation with Troy LeMaile Stovall TEDCO s New CEO and Executive Director BioBuzz

The Maryland Technology Development Corporation (TEDCO) announced in July 2020 that it had completed the executive search for a new leader with the hiring of Troy LeMaile-Stovall, a seasoned leader with deep ties to the BioHealth Capital Region (BCHR).

LeMaile-Stovall just recently officially took the helm of TEDCO and we thought it a great time to catch up with him for a wide-ranging and insightful conversation about his background and vision for TEDCO and the BHCR biotech and life science ecosystem.

Image: https://biobuzz.io

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.